Hainan Honz Pharmaceutical Co (300086) — Cash Flow Quality Index
Hainan Honz Pharmaceutical Co (300086) has a Cash Flow Quality Index of 2.77x as of December 2023. Operating cash flow of CN¥88.62 Million exceeds net income of CN¥31.98 Million, indicating high earnings quality where cash backs reported profits. Explore 300086 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Hainan Honz Pharmaceutical Co Cash Flow Quality Index (2007–2023)
Historical Cash Flow Quality Index for Hainan Honz Pharmaceutical Co across 14 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see cash flow conversion of Hainan Honz Pharmaceutical Co.
Annual Cash Flow Quality Index for Hainan Honz Pharmaceutical Co (2007–2023)
Year-by-year earnings quality comparison for Hainan Honz Pharmaceutical Co.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 13.68x | CN¥70.69 Million | CN¥5.17 Million | ▲ +1176.2% |
| 2021 | 1.07x | CN¥11.33 Million | CN¥10.57 Million | ▲ +227.9% |
| 2020 | -0.84x | CN¥-16.74 Million | CN¥19.99 Million | ▼ -111.2% |
| 2018 | 7.50x | CN¥157.66 Million | CN¥21.02 Million | ▲ +1882.6% |
| 2017 | 0.38x | CN¥18.17 Million | CN¥48.03 Million | ▼ -83.9% |
| 2016 | 2.35x | CN¥90.88 Million | CN¥38.68 Million | ▲ +101.0% |
| 2015 | 1.17x | CN¥78.30 Million | CN¥66.99 Million | ▼ -7.4% |
| 2014 | 1.26x | CN¥73.93 Million | CN¥58.60 Million | ▼ -76.9% |
| 2013 | 5.47x | CN¥78.93 Million | CN¥14.43 Million | ▼ -1.9% |
| 2012 | 5.58x | CN¥109.46 Million | CN¥19.63 Million | ▲ +872.3% |
| 2010 | 0.57x | CN¥79.89 Million | CN¥139.32 Million | ▼ -40.2% |
| 2009 | 0.96x | CN¥93.58 Million | CN¥97.58 Million | ▼ -24.1% |
| 2008 | 1.26x | CN¥62.61 Million | CN¥49.52 Million | ▲ +41.3% |
| 2007 | 0.89x | CN¥30.59 Million | CN¥34.20 Million | — |